Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Judit K Megyesi"'
Autor:
Chhanda Bose, Judit K Megyesi, Sudhir V Shah, Kim M Hiatt, Kimberly A Hall, Oleg Karaduta, Sundararaman Swaminathan
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136563 (2015)
Nephrogenic systemic fibrosis is associated with gadolinium contrast exposure in patients with reduced kidney function and carries high morbidity and mortality. We have previously demonstrated that gadolinium contrast agents induce in vivo systemic i
Externí odkaz:
https://doaj.org/article/f866d2a13fc74b3d9d74e883c4f3bbe7
Autor:
Midhun C Korrapati, Lauren A Howell, Brooke E Shaner, Judit K Megyesi, Leah J Siskind, Rick G Schnellmann
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e73655 (2013)
To determine whether delayed administration of a single dose of suramin, a drug that has been used extensively in humans to treat trypanosomiasis, attenuates renal injury in a leptin receptor deficient C57BLKS/J db/db type 2 diabetic nephropathy (T2D
Externí odkaz:
https://doaj.org/article/89bd3183f4a34945ade783ba141ee564
Autor:
Craig Beeson, Robert B. Cameron, Rick G. Schnellmann, Tess V Dupre, Whitney S. Gibbs, Judit K Megyesi, Siennah R Miller
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 369:173-180
Acute kidney injury (AKI) is the rapid loss of renal function after an insult, and renal proximal tubule cells (RPTCs) are central to the pathogenesis of AKI. The β2-adrenergic receptor (β2AR) agonist formoterol accelerates the recovery of renal fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0564aff145c28bc37a78f31fdec5b5bb
https://doi.org/10.1124/jpet.118.252833
https://doi.org/10.1124/jpet.118.252833